Charles Schwab Investment Management Inc Novartis Ag Transaction History

Charles Schwab Investment Management Inc

  • $557 Billion
  • Q2 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Novartis Ag stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 222,630 shares of NVS stock, worth $29.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
222,630
Previous 185,603 19.95%
Holding current value
$29.3 Million
Previous $20.7 Million 30.2%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 12, 2025
BUY
$101.96 - $121.01 $3.78 Million - $4.48 Million
37,027 Added 19.95%
222,630 $26.9 Million
Q1 2025

Sep 15, 2025
SELL
$97.14 - $115.57 $3.6 Million - $4.28 Million
-37,027 Reduced 16.63%
185,603 $20.7 Million
Q1 2025

May 09, 2025
BUY
$97.14 - $115.57 $1.96 Million - $2.33 Million
20,161 Added 12.19%
185,603 $20.7 Million
Q4 2024

Feb 06, 2025
BUY
$96.78 - $117.18 $792,241 - $959,235
8,186 Added 5.21%
165,442 $16.1 Million
Q3 2024

Nov 12, 2024
BUY
$106.13 - $120.89 $2.02 Million - $2.3 Million
18,990 Added 13.73%
157,256 $18.1 Million
Q2 2024

Aug 12, 2024
BUY
$92.57 - $107.37 $1.63 Million - $1.9 Million
17,662 Added 14.64%
138,266 $14.7 Million
Q1 2024

May 08, 2024
SELL
$95.27 - $108.47 $2.46 Million - $2.8 Million
-25,805 Reduced 17.63%
120,604 $11.7 Million
Q4 2023

Feb 06, 2024
SELL
$92.27 - $101.54 $391 Million - $430 Million
-4,237,440 Reduced 96.66%
146,409 $14.8 Million
Q3 2023

Nov 08, 2023
SELL
$94.73 - $105.13 $2.71 Million - $3.01 Million
-28,592 Reduced 0.65%
4,383,849 $447 Million
Q2 2023

Aug 09, 2023
SELL
$92.52 - $104.91 $4.62 Million - $5.24 Million
-49,942 Reduced 1.12%
4,412,441 $445 Million
Q1 2023

May 11, 2023
SELL
$80.03 - $92.81 $8.51 Million - $9.87 Million
-106,331 Reduced 2.33%
4,462,383 $411 Million
Q4 2022

Feb 13, 2023
BUY
$75.55 - $92.52 $3.12 Million - $3.82 Million
41,253 Added 0.91%
4,568,714 $414 Million
Q3 2022

Nov 14, 2022
BUY
$74.61 - $87.26 $6.21 Million - $7.26 Million
83,210 Added 1.87%
4,527,461 $344 Million
Q2 2022

Aug 15, 2022
BUY
$80.52 - $93.75 $3.63 Million - $4.22 Million
45,038 Added 1.02%
4,444,251 $376 Million
Q1 2022

May 13, 2022
BUY
$80.11 - $90.62 $15.5 Million - $17.5 Million
193,519 Added 4.6%
4,399,213 $386 Million
Q4 2021

Feb 11, 2022
BUY
$79.7 - $88.13 $7.11 Million - $7.86 Million
89,226 Added 2.17%
4,205,694 $368 Million
Q3 2021

Nov 16, 2021
BUY
$81.78 - $95.14 $3.14 Million - $3.65 Million
38,337 Added 0.94%
4,116,468 $337 Million
Q2 2021

Aug 16, 2021
BUY
$85.24 - $94.15 $5.02 Million - $5.54 Million
58,840 Added 1.46%
4,078,131 $372 Million
Q1 2021

May 17, 2021
SELL
$83.5 - $98.47 $45.4 Million - $53.6 Million
-544,058 Reduced 11.92%
4,019,291 $344 Million
Q4 2020

Feb 16, 2021
SELL
$78.07 - $94.43 $18.2 Million - $22 Million
-232,491 Reduced 4.85%
4,563,349 $431 Million
Q3 2020

Nov 13, 2020
SELL
$82.14 - $91.0 $21.4 Million - $23.7 Million
-260,053 Reduced 5.14%
4,795,840 $417 Million
Q2 2020

Aug 14, 2020
SELL
$80.93 - $91.1 $14 Million - $15.7 Million
-172,708 Reduced 3.3%
5,055,893 $442 Million
Q1 2020

May 15, 2020
BUY
$70.67 - $99.01 $306 Million - $428 Million
4,323,827 Added 477.89%
5,228,601 $431 Million
Q4 2019

Feb 07, 2020
BUY
$84.35 - $95.37 $12.1 Million - $13.6 Million
142,947 Added 18.76%
904,774 $85.7 Million
Q3 2019

Nov 08, 2019
BUY
$85.54 - $94.26 $7.59 Million - $8.37 Million
88,776 Added 13.19%
761,827 $66.2 Million
Q2 2019

Aug 09, 2019
BUY
$75.4 - $92.8 $14 Million - $17.2 Million
185,151 Added 37.95%
673,051 $61.5 Million
Q1 2019

May 14, 2019
BUY
$75.32 - $86.15 $36.7 Million - $42 Million
487,900 New
487,900 $46.9 Million

Others Institutions Holding NVS

# of Institutions
1,561
Shares Held
136M
Call Options Held
1.72M
Put Options Held
1.7M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $283B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email